Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company’s
Board of Directors has authorized the repurchase of up to $1.0 billion
of the company’s common stock through January 2011.
Purchases may be made in the open market or in privately negotiated
transactions from time to time, as determined by Gilead’s management and
in accordance with the requirements of the Securities and Exchange
Commission.
The timing and actual number of shares repurchased will depend on a
variety of factors including price, corporate and regulatory
requirements and other market conditions.